|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/24 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Patento numeris | 3085385 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14871536.0 |
| Europos patento paraiškos padavimo data | 2014-12-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2014/093722 |
| Data | 2014-12-12 |
| (87) | Numeris | WO 2015/090162 |
| Data | 2015-06-25 |
| (30) | Numeris | Data | Šalis |
| 201310693338 | 2013-12-16 | CN |
| (72) |
FANG, Weijie , CN
WANG, Haibin , CN
QIU, Minhong , CN
ZHENG, Hongjian , CN
YING, Yuebin , CN
BAI, Hua , CN
|
| (73) |
Hisun Biopharmaceutical Co., Ltd. ,
8 of Haizheng Road, Xukou Town
Fuyang District, Hangzhou City, Zhejiang Province,
CN
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING ADALIMUMAB |
| PHARMACEUTICAL COMPOSITION COMPRISING ADALIMUMAB |